Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Nexus AG's enterprise value is €1,125.4 Mil.
Nexus AG's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was €66.1 Mil. Therefore, Nexus AG's EV-to-EBITDA for today is 17.02.
The historical rank and industry rank for Nexus AG's EV-to-EBITDA or its related term are showing as below:
LTS:0FGL'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.06 Med: 16.53 Max: 31.71
Current: 16.89
During the past 13 years, the highest EV-to-EBITDA of Nexus AG was 31.71. The lowest was 9.06. And the median was 16.53.
LTS:0FGL's EV-to-EBITDA is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 11.14
vs LTS:0FGL: 16.89
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Nexus AG (LTS:0FGL) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Nexus AG's share price for today is €71.70.
Nexus AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.970.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Nexus AG's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0FGL vs VEEV, GEHC, TEM: EV-to-EBITDA Comparison
For the Health Information Services subindustry, Nexus AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexus AG EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nexus AG's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Nexus AG's EV-to-EBITDA falls into.
Nexus AG's current Enterprise Value is €1,125.4 Mil.
Nexus AG's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €66.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nexus AG (LTS:0FGL) has a EV-to-EBITDA of 17.02 as of Jul. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Nexus AG. This is near median its historical median of 16.53. Over the past decade, Nexus AG's EV-to-EBITDA has ranged from 9.06 to 31.71.
Is Nexus AG's EV-to-EBITDA too high?
Nexus AG's current EV-to-EBITDA of 17.02 is near median its 10-year median of 16.53. Over the past 10 years, this metric has ranged from a low of 9.06 to a high of 31.71. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.14. Nexus AG's value of 17.02 is 52.8% above this industry median. Overall, Nexus AG has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Nexus AG's EV-to-EBITDA compare to VEEV and GEHC?
Nexus AG's EV-to-EBITDA of 17.02 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-EBITDA is 11.14. Nexus AG's value of 17.02 is 52.8% above this benchmark. Historically, Nexus AG's own EV-to-EBITDA has ranged from 9.06 to 31.71 over the past decade. While the company's 10-year median is 16.53 vs. the industry median of 11.14, Nexus AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.14, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nexus AG's current EV-to-EBITDA of 17.02 is 52.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Nexus AG. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexus AG's current EV-to-EBITDA is 17.02, which is near median its own 10-year median of 16.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexus AG stock overvalued right now?
Nexus AG (LTS:0FGL) has a current EV-to-EBITDA of 17.02. The stock's GF Value™ is €74.59, compared to a current price of €71.70 — trading 3.9% below its estimated fair value. The current EV-to-EBITDA is 17.02, which is near median its 10-year median of 16.53 and 52.8% above the Healthcare Providers & Services industry median of 11.14. Nexus AG's overall GF Score™ is 11/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Nexus AG (LTS:0FGL), the current EV-to-EBITDA is 17.02 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexus AG (LTS:0FGL) Overvalued in 2026?
Based on GuruFocus' analysis, Nexus AG stock appears to be undervalued.
The current stock price of €71.70 is trading 3.9% below its estimated GF Value™ of €74.59.
Key valuation signals for LTS:0FGL:
EV-to-EBITDA: 17.02 (near median its 10-year median of 16.53)
GF Value™: €74.59 vs. price of €71.70 (3.9% below fair value)
Industry Position: 52.8% above the Healthcare Providers & Services median
No single metric tells the full story. See the LTS:0FGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexus AG is a software solution provider. The company functions through the Healthcare software and Healthcare service segments, which are responsible for providing information systems for hospitals, psychiatric, rehabilitation, and social institutions, and IT services for IT operations especially in healthcare systems. The company derives a majority of its revenues from the Healthcare software segment. Its geographical segments are Germany, Switzerland/Lichtenstein, Netherlands, Poland, France, Austria, and other regions.
11GF Score
Get the complete analysis for LTS:0FGL
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0FGL has been successfully added to your 
